Need Help?
Copied to clipboard!

High-Grade B-Cell Lymphoma: Atlas of Blood Cancer Genomes

High-Grade B-cell Lymphoma (HGBCL) is a biologically aggressive and clinically heterogeneous lymphoma subtype characterized by frequent MYC rearrangements often in combination with BCL2 and/or BCL6 translocations. While both BCL2- and BCL6-rearranged HGBCLs fall under the same diagnostic category, emerging genomic and transcriptomic data suggest distinct molecular features and clinical outcomes between these subgroups. To systematically explore these differences, we comprehensively profiled the clinical and genomic landscape of HGBCL in a cohort of 53 biopsy samples. The cohort was stratified by translocation category: MYC/BCL2, MYC/BCL2/BCL6 (triple-hit, TH), MYC/BCL2/BCL6 (unconfirmed double-hit, unconfirmed TH), and MYC/BCL6. We identified numerous recurrent driver mutations and noted significant enrichment of mutations in genes such as CREBBP, BCL2, EZH2, and GNA13 in BCL2-translocated cases. Patients harboring BCL2 translocations exhibited markedly poorer overall survival, highlighting distinct biological signals potentially driven by these enriched genetic alterations. We observed clear transcriptional differences between BCL2-translocated cases and the MYC/BCL6 group, mirroring the divergent survival outcomes. Collectively, these findings emphasize the clinical and molecular heterogeneity within HGBCL and highlight the importance of integrating translocation status and mutation profiling to enhance prognostic accuracy and inform tailored therapeutic strategies.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000001986 Illumina NovaSeq X 53
EGAD50000001987 Illumina NovaSeq X 48